Sorbent Therapeutics logo — company profile

Sorbent Therapeutics

Founded 2005 Series D Total: $110.09M Biopharma, Biotechnology +1

General Information

Company Name Sorbent Therapeutics
Founded Year 2005
Founders / Decision Makers
Team member Team member
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Sorbent Therapeutics. To contact Sorbent Therapeutics, visit sorbent.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Sorbent Therapeutics

Sorbent Therapeutics is a biopharmaceutical and biotechnology startup that was founded in 2005. The company operates within the biopharma, biotechnology, and pharmaceutical industries, focusing on innovative solutions in the medical field. In May 2014, Sorbent Therapeutics received a significant $6.50M Series D investment from a group of notable investors including Arch Venture Partners, Novartis Venture Fund, Sofinnova Investments, CMEA Capital, and AgeChem Venture Fund. This investment demonstrates the confidence these influential investors have in the potential of Sorbent Therapeutics and its ability to make a significant impact in the biopharmaceutical and biotechnology sectors.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $6.50M 5
Arch Venture Partners, Novartis Venture Fund +3
15 May 2014
Venture Round $2.53M 2
Arch Venture Partners, Sofinnova Investments
01 Apr 2013
Series C $18.06M 3
Arch Venture Partners, Novartis Venture Fund +1
08 Aug 2012
Debt Financing $6.00M -
11 Jun 2012
Series B $36.00M 5
Arch Venture Partners, Novartis Venture Fund +3
30 Jun 2011
Series B $21.80M 4
Arch Venture Partners, Sofinnova Investments +2
13 Sep 2010
Series A $19.20M -
02 Feb 2008
Venture Round Undisclosed 1
Sofinnova Investments
01 Jan 2005

FAQ About Sorbent Therapeutics

Sorbent Therapeutics was founded in 2005.
Sorbent Therapeutics operates in Biopharma, Biotechnology and Pharmaceutical.
Sorbent Therapeutics has completed 8 funding rounds, raising a total of $110.09M. The latest funding stage is Series D.

We're actively collecting intelligence on Sorbent Therapeutics.

Source: BounceWatch company record for Sorbent Therapeutics, https://bouncewatch.com/company/sorbent-therapeutics, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes